Infigratinib
A small-molecule FGFR kinase inhibitor that interferes with growth signaling in tumors carrying specific FGFR2 alterations. It is a prescription oncology drug used for certain FGFR2-driven bile duct cancers (cholangiocarcinoma).
- Sources carrying it
- 2
- Listings indexed
- 4
- Lowest listed
- $340.00
- Median
- $725.00
- Highest listed
- $40,000.00
across 1000mg → 500000mg
Sticker prices in US dollars, across every dosage and pack size (1000mg → 500000mg) — so the spread includes different quantities, not just different sellers. Prices are the sellers' own listed prices, re-checked periodically rather than tracked daily.
Who lists it & for how much
Members only
The 2 sources that list Infigratinib, and what each one charges, are behind the membership. Prices above are the range across every source that lists it — the membership is what tells you which source and for how much, with links and contacts.
Already a member? Sign in
Other raw powders indexed
- RU58841from $22.80
- Phenibutfrom $9.00
- DMAAfrom $17.00
- Fladrafinilfrom $23.00
- DNPfrom $60.00
- Fonturacetam Hydrazidefrom $20.00
- Phenylpiracetamfrom $29.99
- ATX-304from $49.99
- DADAfrom $28.00
- Epinephrinefrom $2.36
- Erdafitinibfrom $124.69
- Sulbutiaminefrom $19.99
Sourcery is an information directory. It does not sell anything and does not handle orders — it indexes what sources publish so they can be compared in one place.